Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel synthetic route for antihistamine intermediate ensures high purity and safety. Reduces toxic waste and enhances supply chain reliability for global pharmaceutical manufacturers.
Patent CN103570601B details a novel synthesis route for chiral intermediates ensuring high purity and cost efficiency for global pharmaceutical supply chains.
Patent CN105603028B reveals dual-enzyme process for glutathione and adenylate. Reduces ATP cost and simplifies purification for reliable supply chain partners.
Novel patent CN105017081A offers high-yield Sitagliptin intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Novel phase-transfer catalysis process for anti-inflammatory intermediates. Reduces dialkylation impurities and simplifies purification for cost-effective API manufacturing.
Improved semi-synthesis of Docetaxel using tribromoacetaldehyde side chain yields higher purity and reduced costs for reliable API intermediate suppliers.
Patent CN111662260B reveals a 7-step synthesis of saffloneoside. Offers stable intermediates and scalable routes for cerebral ischemia drug development.
Patent CN104086488A reveals efficient pyrimidine synthesis enabling cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103073555B reveals high-yield synthesis route. Offers cost reduction in pharma manufacturing and reliable pharmaceutical intermediate supplier capabilities for global supply chains.
Advanced process for cephalosporin derivatives using selective activated carbon adsorption. Enhances Z-isomer purity and reduces phenylacetic acid impurities for pharmaceutical manufacturing.
Patent CN104830744A details a novel SD-AS coupled enzyme method for (R)-phenylglycol. Achieves 100% e.e. and 99.9% yield, offering significant cost reduction and supply reliability for pharmaceutical manufacturing.
Novel low-temperature esterification process for estradiol derivatives. Enhances yield and purity while reducing toxic reagent usage for global supply chains.
Patent CN105481925A reveals a novel catalytic transfer hydrogenation route for high-purity Obeticholic Acid intermediates, ensuring supply chain reliability.
Patent CN109021147B reveals a novel organic acid-base purification method for Sugammadex Sodium, eliminating dialysis and ensuring >99.5% purity with controlled oxidation impurities.
Patent CN112941114A reveals high-purity enzymatic route for chiral triols. Reduces production cost and improves supply chain reliability for global pharmaceutical intermediates manufacturing.
Patent CN116751242A reveals mild esterification for estradiol derivatives ensuring high purity and green chemistry compliance for reliable pharmaceutical intermediates supply chains globally.
Patent CN115057840B details a visible light-promoted synthesis of 3-acyl coumarins. This method offers cost reduction in fine chemical manufacturing and high-purity intermediates.
Patent CN114381441B reveals imine reductase catalysis for optical pure chiral amino alcohols. Offers mild conditions and high stereoselectivity for pharmaceutical supply chains.
Patent CN1978442A details a novel mannitol-based route for Nepyrrolol HCl, offering improved purity and scalability for reliable pharmaceutical intermediate suppliers.
Patent CN115948356B reveals high-efficiency carbonyl reductase mutants for lipoic acid intermediates, offering supply chain stability and cost reduction.